# APIXABAN
> **ANDA210067** · Abbreviated New Drug Application (Generic) · Sponsor: MACLEODS PHARMS LTD · Approved 2025-02-27
## Drug
- **FDA Application Number:** ANDA210067
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** APIXABAN
- **Generic name:** APIXABAN
- **Active ingredients:** APIXABAN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** MACLEODS PHARMS LTD
- **Manufacturer:** Macleods Pharmaceuticals Limited
- **First approval:** 2025-02-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210067)
---
*AI Analytics · CC0 1.0*